 |
|
|
|
About Talecris Biotherapeutics
|
|
|
At Talecris, we understand that our employees, not our company name, define our organization. While Talecris continues to be the people you've known and trusted over the years, we've added some new talent to our team—employees that share our commitment to patient care.
We'd like you to know about some of the Talecris Talent that makes it all possible.
| |
Larry Stern
John M. Hanson, C.P.A.
John F. Gaither, Jr.
Mary Kuhn
Steve Petteway, Ph.D.
Tom Lynch, Ph.D.
Randy Jones
Bruce Nogales
Jim Engle
Kari Heerdt
Dan Menichella
Joel Abelson
John Perkins
|
|
Larry Stern
Chairman and Chief Executive Officer
Lawrence (Larry) Stern is the Chairman and Chief Executive Officer of Talecris Biotherapeutics. Mr. Stern joined Talecris in April 2005 from Cerberus Capital Management, where he led the evaluation and plan resulting in the contribution of assets of the plasma portion of Bayer Biological Products to Talecris Biotherapeutics.
Mr. Stern joined Bayer Corporation as the President of its Urethanes group in 2000 upon Bayer's $2.5 billion acquisition of Lyondell Chemical's polyol business. Mr. Stern successfully completed a complex, multi-national integration with diverse cultural perspectives and business practices. He led significant restructurings including consolidation of manufacturing plants and R&D facilities, while simultaneously improving operational reliability.
Mr. Stern has a passion for Operational Excellence, and has led dramatic improvements in cost, safety, and environmental performance throughout his career.
Mr. Stern received his B.S. in Chemical Engineering from Cornell University in 1979. He completed his M.S. from the Massachusetts Institute of Technology with a thesis on Fluidized Bed Coal Combustion in 1981.
|
|
John M. Hanson, C.P.A.
Executive Vice President and Chief Financial Officer
John M. Hanson, C.P.A., became Executive Vice President and Chief Financial Officer of Talecris Biotherapeutics in October 2005. Mr. Hanson joined Talecris from Andrx Corporation where he served as Senior Vice President and Chief Financial Officer. In addition to oversight of all financial functions, he led the design and implementation of Andrx's Sarbanes-Oxley Section 404 compliance, the creation of a shared-services platform to improve financial efficiencies and effectiveness, as well as an effort to improve public financial reporting and investor communications.
Prior to Andrx, Mr. Hanson served as Chief Financial Officer for Mylan Laboratories, Inc., a leader in generic pharmaceutical development, manufacture and marketing. Mr. Hanson came to Mylan after 5 years with IVAX Corporation, an international pharmaceutical company. His last position at IVAX was as the Chief Financial Officer of Zenith-Goldline Pharmaceuticals, now IVAX Pharmaceuticals, IVAX's US generic pharmaceutical company. Mr. Hanson began his career in public accounting with Arthur Andersen.
Mr. Hanson attended the University of South Dakota, where he received a Bachelor of Science in Biology and a Masters of Professional Accountancy and was recognized as the Outstanding Graduate by his graduate school program.
|
|
John F. Gaither, Jr.
Executive Vice President, General Counsel and Corporate Secretary
John F. Gaither, Jr. joined Talecris in September 2006 as Executive Vice President, General Counsel and Corporate Secretary.
Prior to joining Talecris, he served as senior vice president, general counsel and corporate secretary of NeighborCare, Inc., which, until acquired, was one of the nation’s leading institutional pharmacy providers.
From 2000 until 2003, Mr. Gaither served as vice president, general counsel and corporate secretary of Global Healthcare Exchange, LLC. GHX provides business-to-business procurement solutions for the healthcare industry.
From 1982 to 2000, Mr. Gaither held various leadership positions with Baxter International, Inc., a leading manufacturer and marketer of healthcare products and services. He served as deputy general counsel and corporate vice president, corporate development, responsible for acquisitions, divestitures, joint ventures and similar major transactions, and Internet strategy. Prior to joining Baxter, Mr. Gaither was in private practice with a Chicago law firm.
Mr. Gaither received a bachelor's degree in accounting with high honors in 1971, and a juris doctor degree, summa cum laude, in 1974 from the University of Notre Dame. He served on active duty in the U.S. Navy for three years, attaining the rank of lieutenant commander in the Judge Advocate General Corps.
Mr. Gaither is a member of the Illinois and Indiana Bar Associations and a Certified Public Accountant.
|
|
Mary Kuhn
Senior Vice President, Operations
Mary Kuhn is Senior Vice President of Operations for Talecris Biotherapeutics.
Mrs. Kuhn began her career at Bayer HealthCare in 1982 in West Haven, Connecticut as a research scientist. Over the next two decades, she held numerous positions with increasing responsibility within Bayer's North American Pharmaceutical Division's Headquarters, including Supervisor, Pharmaceutical Formulations Lab; Manager, Pharmaceutical Technical Services; Manager, Manufacturing Operations; Director, Manufacturing; and, Vice President, Technical Operations and Ethical Product Manufacturing.
Prior to accepting her current position in Clayton in October 2002, Mrs. Kuhn served as Vice President, Operations, for Bayer Corporation's Pharmaceutical Division in West Haven.
Mrs. Kuhn holds a B.S. in pharmacy from Purdue University in West Lafayette, Indiana and a master's degree in business administration from the University of New Haven in Connecticut.
|
|
Steve Petteway, Ph.D.
Senior Vice President, Research and Development
As Senior Vice President, Research and Development, Steve Petteway is responsible for the preclinical and clinical development, production, and safety of Talecris' protein therapeutics. Dr. Petteway has 23 years of experience in the discovery, development, and production of therapeutics and diagnostics.
Dr. Petteway joined Talecris' predecessor, Bayer Biological Products, in 1995. He and his colleagues have been instrumental in establishing prion and virus removal profiles for plasma derived and recombinant manufacturing processes, as well as the development of new protein manufacturing processes and products.
Prior to joining Bayer, Dr. Petteway was Director of Drug Development for Cato Research Ltd., Vice President and Co-founder of Trimeris Inc., and Director of Molecular Virology and Host defense for SmithKline Beecham Pharmaceuticals. Dr. Petteway also worked for DuPont, where he was focused on the production of recombinant proteins and the development of diagnostics and blood screening tests. He is a consultant for biotech venture investments, has served on the scientific advisory boards for various biotech companies, and is the author of numerous scientific publications and patents related to diagnostics and therapeutics.
Dr. Petteway holds a Bachelor's degree in Microbiology/Chemistry from The University of South Florida and a Ph.D. in Molecular Cell Biology from The University of Alabama in Birmingham Medical Center.
|
|
Tom Lynch, Ph.D.
Senior Vice President, Corporate Compliance Regulatory and Public Affairs
Tom Lynch was recruited into the newly formed Talecris Biotherapeutics as VP of Corporate Governance and Compliance in April 2005, and assumed his current position in early 2006. Dr. Lynch joined Talecris from CryoLife, Inc., a medical device and human tissue company where he was VP of Regulatory Affairs and Quality Assurance.
Prior to joining CryoLife in 2003, Dr. Lynch was a founding member of a biotechnology company, Clearant, which was formed to develop and implement new methods of inactivating pathogens in biological therapeutic products, medical devices, and devitalized tissues.
From 1993 to 2000, Dr. Lynch worked for the US Food and Drug Administration, most recently as Deputy Director of the Division of Hematology. At the FDA, his principal responsibilities involved the regulation of therapeutic proteins derived from human plasma or produced by genetic or transgenic engineering.
Prior to joining the FDA, Dr. Lynch spent approximately 15 years as a research scientist in various capacities in the public, academic and private sectors. He holds a Ph.D. in biochemistry from Wayne State University and a law degree from Georgetown.
|
|
Randy Jones
Senior Vice President, Special Projects
As Senior Vice President, Special Projects, Randy Jones serves in the Office of the Chief Executive, supporting a variety of projects and initiatives of strategic importance to Talecris.
Since joining Talecris' predecessor, Bayer Biological Products, in 2003, Mr. Jones has held various leadership positions of increasing responsibility including Senior Vice President, Human Resources and Vice President and General Counsel.
Prior to joining Talecris, Mr. Jones served as General Counsel for the North American operations of Rhône-Poulenc Ag Company and Aventis CropScience USA in Research Triangle Park. He was also the Managing Director and Assistant General Counsel for Molten Metal Technology Inc., an environmental technology company based in Waltham, Massachusetts. Before attending law school, Mr. Jones was an engineer for Shell Oil Company in New Orleans and the Standard Oil Company of Ohio (now BP) in Cleveland.
Mr. Jones holds a bachelor’s degree in Chemical Engineering from the University of Delaware in Newark, Delaware and a juris doctor from the University of Virginia in Charlottesville, Virginia.
|
|
Bruce Nogales
Senior Vice President and General Manager, Talecris Plasma Resources
As Senior Vice President and General Manager, Talecris Plasma Resources, Bruce Nogales is responsible for ensuring the adequate supply of plasma raw material to support Talecris’ long-term growth plan, while meeting cost, quality and regulatory standards.
Since joining Talecris in 2005, Mr. Nogales has held various leadership positions. Most recently, he served as Vice President and General Manager, International Commercial Operations. In that role, he was responsible for both the general management of Talecris’ intercontinental business and the establishment of Talecris’ commercial structure in Canada and throughout Europe.
Other key positions held by Mr. Nogales at Talecris include Vice President of both the Global Immunology and Global Pulmonary franchises. In these roles, Mr. Nogales had responsibility for strategic planning, business analysis and development, global branding, and product development for these business areas. He utilized key interfaces with Commercial Operations, Research and Development, Manufacturing, Finance and Information Solutions to establish global long-term objectives, to design business plans and to direct and support project teams to implement essential programs.
Mr. Nogales is a proven leader with more than 27 years of progressive experience in the pharmaceutical, medical device, biotechnology, biologic and financial industries. Prior to joining Talecris, Mr. Nogales held various leadership positions with Aventis Behring LLC, Genzyme Corporation and Allergan, Inc.
Mr. Nogales received his Bachelor of Science in Finance from California State University, Long Beach, California and completed an Executive Development Program at the University of Pennsylvania’s Wharton School of Business.
|
|
Jim Engle
Senior Vice President, Information Solutions and Chief Information Officer
As Senior Vice President, Information Solutions and Chief Information Officer, Jim Engle is responsible for the strategic application of information technology across all Talecris’ business platforms.
Since joining Talecris in April 2005, Mr. Engle and his team have been responsible for the successful implementation of numerous Information Solutions projects and strategic investments associated with the future growth of Talecris. Prior to joining Talecris, Mr. Engle served as Chief Information Officer and Senior Vice President, Information Technology for ZLB Behring. He also held various Information Solutions leadership positions with Aventis Pharmaceuticals and Johnson and Johnson.
Mr. Engle is a proven leader with more than 30 years experience within the information technology field. He earned his Bachelor of Science in Business Administration from Delaware Valley College of Science and Agriculture.
|
|
Kari Heerdt
Senior Vice President, Human Resources
As Senior Vice President of Human Resources, Kari Heerdt is responsible for managing Talecris’ Human Resources systems, programs and policies including employee recruitment, retention, compensation and benefits as well as organizational and leadership development.
Ms. Heerdt is a seasoned Human Resources executive with more than 18 years of related management and consulting experience. Prior to joining Talecris, Ms. Heerdt served as Senior Vice President of Human Resources for Mervyns, a mid-market department store. She also served as a Senior Manager for Cerberus Capital Management, a leading investment management firm, and as a Senior Consultant for Hewitt Associates, a global Human Resources consulting and outsourcing services firm. Ms. Heerdt also held various Human Resources leadership positions within General Electric.
Ms. Heerdt earned a Bachelor of Arts degree from Mount Holyoke College in South Hadley, Massachusetts and a Master of Science degree from the Krannert Graduate School of Management at Purdue University in West Lafayette, Indiana.
|
|
Dan Menichella
Senior Vice President, Business Development
As Senior Vice President of Corporate Business Development, Daniel Menichella leads the Mergers and Acquisitions and Licensing department. Along with his team, he is responsible for identifying and pursuing growth opportunities and for executing these strategically important initiatives.
Mr. Menichella is a seasoned Business Development professional with more than 20 years of commercial and life sciences corporate development experience. Prior to joining Talecris, Mr. Menichella held various positions of increasing responsibility at Merck KGaA; including Vice President, Corporate Strategy and Vice President, Corporate Business Development and Alliance Management. While at Merck, Mr. Menichella played an instrumental role in a number of major licensing, merger and acquisition projects including Merck's 10.6 billion euro acquisition of the Serono business. He also served as President of MorphoSys USA and Senior Vice President of MorphoSys AG, a biotech company focused on therapeutic antibodies.
Mr. Menichella earned a Bachelor of Arts degree from Harvard University and a Masters of Business Administration from the University of North Carolina at Chapel Hill.
|
|
Joel Abelson
Senior Vice President and General Manager, Portfolio Management and International Business
As Senior Vice President and General Manager, Portfolio Management and International Business, Mr. Abelson leads Talecris’ Canadian and Intercontinental Operations as well as Operations in Germany and the European Union. Mr. Abelson has joint responsibility for global portfolio management and plays a pivotal role in developing and implementing strategies to support Talecris’ global expansion.
Mr. Abelson joined Talecris in March 2006 as Vice President, Canada and Intercontinental Commercial Operations with responsibilities for the planning and establishment of Talecris’ Canadian business and Talecris’ commercial operations in all markets outside the US and Europe.
Prior to joining Talecris, Mr. Abelson was with Bayer Healthcare where he held several senior management positions in Canada and the US, including Vice President, Global Strategic Marketing, where he was responsible for marketing strategies across the entire product portfolio. Prior to that, he was Vice President, Immunology Life Cycle Management, where he was responsible for strategic marketing and preparing the company for the launch of Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate / Chromatography Purified).
Prior to joining the private sector, Mr. Abelson held various policy and management positions with the Government of Ontario, Canada including service in the Cabinet Office as a Senior Policy Advisor to the Premier’s Policy and Priorities Committee. He also led the Province’s joint private/public sector health economic development initiative to accelerate the growth of the Province’s pharmaceutical, biotechnology and medical device sectors.
Mr. Abelson has a Bachelor of Arts (Honours) degree from Carleton University in Ottawa, Canada and a Master’s degree in Public Administration from the University of Toronto.
|
|
John Perkins
Senior Vice President and General Manager, Portfolio Management and U.S. Business
Mr. Perkins joined Talecris Biotherapeutics in 2006 and currently serves as the Senior Vice President and General Manager, Portfolio Management and U.S. Business. In this leadership position, he has profit and loss responsibility for the U.S. business which is comprised of ten products that generate over $750M in sales. In addition, Mr. Perkins has joint responsibility for global portfolio management with direct responsibility for Global Immunology, Hematology, Thrombosis and overall Market Research and Business Intelligence. Mr. Perkins also serves on the Board of Directors for Centric Health Resources.
Prior to joining Talecris, Mr. Perkins was a consultant to Cerberus Capital Management, where he provided executive management for portfolio companies, including Talecris, and for potential investments.
Mr. Perkins joined Cerberus from General Electric where he was an executive in its Corporate Business Development (Mergers & Acquisitions) group. Mr. Perkins started his career with General Electric, where he held a variety of positions in marketing/product management, sales, operations and Corporate Audit. In addition to his experience at General Electric, he worked in Business Development for a start-up in Silicon Valley, California.
Mr. Perkins is a graduate of General Electric’s Management Development Program and is a certified Six Sigma Black Belt. He received his Bachelor of Arts from DePauw University, Greencastle, Indiana, and earned his Master of Business Administration degree from Northwestern University’s Kellogg School of Management in Evanston, Illinois.
|
|
|
|
|
|
|
Consider a Talecris Career for personal satisfaction and professional growth.
|
|
